ClinicalTrials.gg
Drug

rimabotulinumtoxinB clinical trials

Also written MYOBLOC and botulinum toxin type B.

studies test it
18
open now
0
in phase 3
6
first study started
2001

How each study uses rimabotulinumtoxinB is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
8 Dec 2000 · MYOBLOC · BLA 103846 (FDA, Drugs@FDA)
European Union
22 Jan 2001 · NeuroBloc · EMEA/H/C/000301 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

rimabotulinumtoxinB
4
Botulinum Toxin Type B (Myobloc)
2
Phase 2; High Dose MYOBLOC (20,000 Units)
2
Phase 3; MYOBLOC
2

Brand

MYOBLOC
7
Neurobloc
1

Other names

botulinum toxin type B
7
Botulinum B Toxin
1

Studies by the year they started

18 studies that test it; most in 2003 (2)

Studies that test rimabotulinumtoxinB, by start year
YearStudies
20011
20021
20032
20041
20061
20071
20082
20132
20141
20151
20161
20171
20191
20212

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
9
Phase 3
6
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 9

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC (4) · Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (3) · Gunma University (1) · University Hospital of North Norway (1) · Georgetown University (1) · Columbia University (1) · Eisai Co., Ltd. (1) · Eisai Limited (1)

Often tested with

Tested in the same studies.

Botulinum toxin type A (2) · Onabotulinum toxin A (1)

Studies

Open first, then newest update. How each study uses rimabotulinumtoxinB is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call rimabotulinumtoxinB · ClinicalTrials.gg INT003872

  • MeSH (NLM) C096323rimabotulinumtoxinBConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 0Y70779M1FRIMABOTULINUMTOXINBConfirmed FDA, NLM
  • RxNorm 860178One source FDA
  • NCI Thesaurus C87453RimabotulinumtoxinbOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.